Recognized standard
E2834-12 (Reapproved 2022)
FDA recognition 18-7 · ASTM · Nanotechnology
Key facts
| Recognition number | 18-7 |
|---|---|
| Designation | E2834-12 (Reapproved 2022) |
| Title | Standard Guide for Measurement of Particle Size Distribution of Nanomaterials in Suspension by Nanoparticle Tracking Analysis (NTA) |
| Standards developer | ASTM International |
| Specialty area | Nanotechnology |
| Date of entry | Jan 14, 2019 |
| Scope (excerpt) | 1.1 This guide deals with the measurement of particle distribution of suspended particles, from ~10nm to the onset of sedimentation, sample dependent, using the nanoparticle tracking analysis (NTA) technique. It does not provide a complete measurement methodology for any specific nanomaterial, but… |
At a glance
- None Product codes
- 1–9 FDA guidance documents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA-recognized consensus standards
The FDA recognizes voluntary consensus standards that manufacturers can cite in premarket submissions to show conformity with specific requirements.
Source: U.S. Food and Drug Administration (FDA), Recognized Consensus Standards database · Source date: